$415.78
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Country

US

CEO

Ms. Gail Boudreaux

IPO date

2001

Employees

96,129

ISIN

US0367521038

Key stats

Open

$420.08

Volume

1.06M

Market cap

$91.29B

Prev. close

$420.39

Impl / hst vl

-

Open interest

$0.00

$416.34

Day’s Range

$422.06

$274.84

52W Range

$427.64

Valuation

44
Valuation score
Fairly Valued
P/E
17.55
P/S
0.46
P/B
2.10
Current ratio
-
Debt / Equity
0.51
ROE
11.95%
Gross margin
-
Income growth
222.49%
FCF growth
-2,060.29

Jun

25

Dividends

The last payment date was Jun 25, 2026

Div. per Share

$1.72

Div. Yield

0.41%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 12 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$424.65
The top 25 analysts forecasts that 12-month price may increase by 2.13%, with a low of $334.31 and a high of $522.90
$334.31
Low
$424.65
Avg
$522.90
High
Current price

Earnings

Q1 ‘26 revenue
$50.18B
Q1 ‘26 net income
$1.76B
Revenue
Net income
Previous EPS
$12.58
Estimate EPS
$6.26
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply